150 related articles for article (PubMed ID: 9861333)
1. Bone mineral density in women with cytotoxic-induced ovarian failure.
Howell SJ; Berger G; Adams JE; Shalet SM
Clin Endocrinol (Oxf); 1998 Sep; 49(3):397-402. PubMed ID: 9861333
[TBL] [Abstract][Full Text] [Related]
2. Reduced bone mineral density in men following chemotherapy for Hodgkin's disease.
Holmes SJ; Whitehouse RW; Clark ST; Crowther DC; Adams JE; Shalet SM
Br J Cancer; 1994 Aug; 70(2):371-5. PubMed ID: 8054287
[TBL] [Abstract][Full Text] [Related]
3. The impact of mild Leydig cell dysfunction following cytotoxic chemotherapy on bone mineral density (BMD) and body composition.
Howell SJ; Radford JA; Adams JE; Shalet SM
Clin Endocrinol (Oxf); 2000 May; 52(5):609-16. PubMed ID: 10792341
[TBL] [Abstract][Full Text] [Related]
4. Bone mineral density in young women with primary ovarian insufficiency: results of a three-year randomized controlled trial of physiological transdermal estradiol and testosterone replacement.
Popat VB; Calis KA; Kalantaridou SN; Vanderhoof VH; Koziol D; Troendle JF; Reynolds JC; Nelson LM
J Clin Endocrinol Metab; 2014 Sep; 99(9):3418-26. PubMed ID: 24905063
[TBL] [Abstract][Full Text] [Related]
5. Differential effects of hormone replacement therapy on bone mineral density and axial transmission ultrasound measurements in cortical bone.
Knapp KM; Blake GM; Spector TD; Fogelman I
Osteoporos Int; 2003 Jun; 14(4):289-94. PubMed ID: 12730793
[TBL] [Abstract][Full Text] [Related]
6. Effects on bone mass after eight years of hormonal replacement therapy.
Eiken P; Nielsen SP; Kolthoff N
Br J Obstet Gynaecol; 1997 Jun; 104(6):702-7. PubMed ID: 9197874
[TBL] [Abstract][Full Text] [Related]
7. Bone mineral density, growth, and thyroid function in long-term survivors of pediatric Hodgkin's lymphoma treated with chemotherapy only.
van Beek RD; van den Heuvel-Eibrink MM; Hakvoort-Cammel FG; van den Bos C; van der Pal HJ; Krenning EP; de Rijke YB; Pieters R; de Muinck Keizer-Schrama SM
J Clin Endocrinol Metab; 2009 Jun; 94(6):1904-9. PubMed ID: 19293271
[TBL] [Abstract][Full Text] [Related]
8. Long-term change in the bone mineral density of adults with adult onset growth hormone (GH) deficiency in response to short or long-term GH replacement therapy.
Rahim A; Holmes SJ; Adams JE; Shalet SM
Clin Endocrinol (Oxf); 1998 Apr; 48(4):463-9. PubMed ID: 9640413
[TBL] [Abstract][Full Text] [Related]
9. [Study on risk factors of cardiovascular disease and the status of bone mineral density in women with hypoestrogenism].
Zhao F; Guo XT; Cheng Y; Yang ZF; Liu HP
Zhonghua Fu Chan Ke Za Zhi; 2013 Oct; 48(10):734-9. PubMed ID: 24406128
[TBL] [Abstract][Full Text] [Related]
10. Bone mineral density loss during adjuvant chemotherapy in pre-menopausal women with early breast cancer: is it dependent on oestrogen deficiency?
Cameron DA; Douglas S; Brown JE; Anderson RA
Breast Cancer Res Treat; 2010 Oct; 123(3):805-14. PubMed ID: 20686833
[TBL] [Abstract][Full Text] [Related]
11. Reduced bone mineral density in patients with adult onset growth hormone deficiency.
Holmes SJ; Economou G; Whitehouse RW; Adams JE; Shalet SM
J Clin Endocrinol Metab; 1994 Mar; 78(3):669-74. PubMed ID: 8126140
[TBL] [Abstract][Full Text] [Related]
12. Long-term follow-up of bone density, general and reproductive health in female survivors after treatment for haematological malignancies.
Naessén S; Bergström I; Ljungman P; Landgren BM
Eur J Haematol; 2014 Aug; 93(2):137-42. PubMed ID: 24649942
[TBL] [Abstract][Full Text] [Related]
13. Reduced bone mineral density in young adults following cure of acute lymphoblastic leukaemia in childhood.
Brennan BM; Rahim A; Adams JA; Eden OB; Shalet SM
Br J Cancer; 1999 Apr; 79(11-12):1859-63. PubMed ID: 10206305
[TBL] [Abstract][Full Text] [Related]
14. Effects of Hormone Replacement Therapy on Bone Mass After Allogeneic Hematopoietic Stem Cell Transplantation.
Ha J; Park SS; Park S; Yoon JH; Baek KH; Kim HJ; Lee S; Kim MR; Kang MI; Lee JW
J Clin Endocrinol Metab; 2020 Sep; 105(9):. PubMed ID: 32594134
[TBL] [Abstract][Full Text] [Related]
15. Hormone Replacement Therapy Versus the Combined Oral Contraceptive Pill in Premature Ovarian Failure: A Randomized Controlled Trial of the Effects on Bone Mineral Density.
Cartwright B; Robinson J; Seed PT; Fogelman I; Rymer J
J Clin Endocrinol Metab; 2016 Sep; 101(9):3497-505. PubMed ID: 27340881
[TBL] [Abstract][Full Text] [Related]
16. Discordance between changes in bone mineral density measured at different skeletal sites in perimenopausal women--implications for assessment of bone loss and response to therapy: The Danish Osteoporosis Prevention Study.
Abrahamsen B; Stilgren LS; Hermann AP; Tofteng CL; Bärenholdt O; Vestergaard P; Brot C; Nielsen SP
J Bone Miner Res; 2001 Jul; 16(7):1212-9. PubMed ID: 11450696
[TBL] [Abstract][Full Text] [Related]
17. Randomized placebo-controlled trial of testosterone replacement in men with mild Leydig cell insufficiency following cytotoxic chemotherapy.
Howell SJ; Radford JA; Adams JE; Smets EM; Warburton R; Shalet SM
Clin Endocrinol (Oxf); 2001 Sep; 55(3):315-24. PubMed ID: 11589674
[TBL] [Abstract][Full Text] [Related]
18. No impact of disease and its treatment on bone mineral density in survivors of childhood acute lymphoblastic leukemia.
Jain S; Jain S; Kapoor G; Virmani A; Bajpai R
Pediatr Blood Cancer; 2017 Apr; 64(4):. PubMed ID: 27671543
[TBL] [Abstract][Full Text] [Related]
19. The influence of gender on the short and long-term effects of growth hormone replacement on bone metabolism and bone mineral density in hypopituitary adults: a 5-year study.
Drake WM; Rodríguez-Arnao J; Weaver JU; James IT; Coyte D; Spector TD; Besser GM; Monson JP
Clin Endocrinol (Oxf); 2001 Apr; 54(4):525-32. PubMed ID: 11318789
[TBL] [Abstract][Full Text] [Related]
20. Effect of combined risedronate and hormone replacement therapies on bone mineral density in postmenopausal women.
Harris ST; Eriksen EF; Davidson M; Ettinger MP; Moffett AH; Baylink DJ; Crusan CE; Chines AA
J Clin Endocrinol Metab; 2001 May; 86(5):1890-7. PubMed ID: 11344179
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
